Autoimmunity and Inflammation in X-linked Agammaglobulinemia

Journal of Clinical Immunology

Volumn 34, Issue 6, 2014, Pages 627-632

  Hernandez Trujillo, Vivian P ^a   Scalchunes, Chris ^b   Cunningham Rundles, Charlotte ^c   Ochs, Hans D ^d   Bonilla, Francisco A ^e   Paris, Ken ^f   Yel, Leman ^g,h   Sullivan, Kathleen E ⁱ  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b Immune Deficiency Foundation   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BAXTER HEALTHCARE CORPORATION   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

antibody deficiency; autoimmune; inflammation; primary immunodeficiency; X linked agammaglobulinemia

Indexed keywords

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; ARTHRITIS; AUTOIMMUNITY; CHILD; CROHN DISEASE; FEMALE; GENETIC DISEASES, X-LINKED; HUMAN; IMMUNOLOGY; INFANT; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INFORMATION PROCESSING; MALE; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; ARTHRITIS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; DATA COLLECTION; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; INFANT; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 84939884251     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0056-x     Document Type: Article

References (25)

1. Conley ME, Rohrer J. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia. Clinical Immunology & Immunopathology. 1995;76(3 Pt 2):S192–7.
2. Vihinen M, Kwan SP, Lester T, Ochs HD, Resnick I, Valiaho J, et al. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Human Mutation. 1999;13(4):280–5.
3. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore). 1985;64(3):145–56.
4. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193–202.
5. Cunningham-Rundles C. Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin Exp Immunol. 2011;164 Suppl 2:6–11.
6. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood. 2002;99(8):2694–702.
7. Howard V, Greene JM, Pahwa S, Winkelstein JA, Boyle JM, Kocak M. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol. 2006;118(2–3):201–8.
8. Jacobs ZD, Guajardo JR, Anderson KM. XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol. 2008;30(8):631–4.
9. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80(4):590–4.
10. Taylor-Robinson D, Furr PM. Protection of mice against vaginal colonisation by Mycoplasma pulmonis. J Med Microbiol. 1994;40(3):197–201.
11. Ng YS, Wardemann H, Chelnis J, Cunningham-Rundles C, Meffre E. Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med. 2004;200(7):927–34.
12. Gonzalez-Serrano ME, Estrada-Garcia I, Mogica-Martinez D, Gonzalez-Garay A, Lopez-Herrera G, Berron-Ruiz L, et al. Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia. J Clin Immunol. 2012;32(5):967–74.
13. Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol. 2011;12(5):416–24.
14. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.
15. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–7.
16. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–86.
17. Cunningham-Rundles C, Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol. 2005;115(2):147–53.
18. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol. 2006;176(3):1978–87.
19. Park J, Munagala I, Xu H, Blankenship D, Maffucci P, Chaussabel D, et al. Interferon signature in the blood in inflammatory common variable immune deficiency. PLoS One. 2013;8(9):e74893.
20. Yu JE, Knight AK, Radigan L, Marron TU, Zhang L, Sanchez-Ramon S. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol. 2009;124(2):349–56.
21. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23(8):1407–17.
22. St Sauver JL, Hagen PT, Cha SS, Bagniewski SM, Mandrekar JN, Curoe AM, et al. Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc. 2005;80(2):203–10.
23. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clinical immunology. 2002;104(3):221–30.
24. Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Alizadeh H, Gharagozlou M, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology. 2010;15(2):289–95.
25. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12(38):6102–8.